Enhanced antioxidant defenses and resistance to TNF-α in a glycolysis-depleted lung epithelial cell line

Free Radical Biology and Medicine

Volumn 33, Issue 10, 2002, Pages 1409-1418

  Boada, Jordi ^a   Cuesta, Eduardo ^a   Roig, Teresa ^a   Gmez, Antonio ^b   Carbonell, Teresa ^a   Ventura, Francesc ^a   Bermdez, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

6 Phosphofructo 2 kinase fructose 2,6 bisphosphatase; Catalase; Free oxygen radicals; Fructose 2,6 bisphosphate; Glutathione; Glutathione peroxidase; Nuclear transcription factor B; Pentose phosphate pathway; Tumor necrosis factor

Indexed keywords

ANTIOXIDANT; CATALASE; ENZYME; FRUCTOSE 2,6 BISPHOSPHATASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BETA GALACTOSIDASE; GLUTAMATE CYSTEINE LIGASE; LUCIFERASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA VECTOR; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSFECTION; GLYCOLYSIS; LUNG ALVEOLUS EPITHELIUM; MINK; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; ANIMAL; CELL LINE; CELL NUCLEUS; CELL SEPARATION; DOSE RESPONSE; FLOW CYTOMETRY; LUNG; METABOLISM;

MUSTELA VISON;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BETA-GALACTOSIDASE; CELL LINE; CELL NUCLEUS; CELL SEPARATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FLOW CYTOMETRY; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYCOLYSIS; LUCIFERASES; LUNG; MINK; NF-KAPPA B; OXIDATION-REDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037111270     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01085-7     Document Type: Article

References (70)

1. Greiner E.F., Guppy M., Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269:1994;31484-31490.
2. Brand K. Aerobic glycolysis by proliferating cells protection against oxidative stress at the expense of energy yield . J. Bioenerg. Biomembr. 29:1997;355-364.
3. Chesney J., Mitchell R., Benigni F., Bacher M., Spiegel L., Al Abed Y., Han J.H., Metz C., Bucala R. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element role in tumor cell glycolysis and the Warburg effect . Proc. Natl. Acad. Sci. USA. 96:1999;3047-3052.
4. Mavier P., Guigui B., Preaux A.M., Rosenbaum J., Lescs M.C., Zafrani E.S., Dhumeaux D. In vitro toxicity of hydrogen peroxide against normal vs. tumor rat hepatocytes role of catalase and of the glutathione redox cycle . Hepatology. 8:1988;1673-1678.
5. Mathupala S.P., Heese C., Pedersen P.L. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J. Biol. Chem. 272:1997;22776-22780.
6. Hue L., Rider M.H. Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Biochem. J. 245:1987;313-324.
7. Pilkis S.J., Claus T.H., Kurland I.J., Lange A.J. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase a metabolic signaling enzyme . Annu. Rev. Biochem. 64:1995;799-835.
8. Bosca L., Mojena M., Ghysdael J., Rousseau G.G., Hue L. Expression of the v-src or v-fps oncogene increases fructose 2,6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem. J. 236:1986;595-599.
9. Mojena M., Bosca L., Rider M.H., Rousseau G.G., Hue L. Inhibition of 6-phosphofructo-2-kinase activity by mercaptopurines. Biochem. Pharmacol. 43:1992;671-678.
10. Manzano A., Rosa J.L., Ventura F., Perez J.X., Nadal M., Estivill X., Ambrosio S., Gil J., Bartrons R. Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase gene (PFKFB3). Cytogenet. Cell Genet. 83:1998;214-217.
11. Minchenko A., Leshchinsky I., Opentanova I., Sang N., Srinivas V., Armstead V., Caro J. Hypoxia-inducible factor-1 (HIF-1) mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKBF3) gene its possible role in the Warburg effect . J. Biol. Chem. 277:2002;6183-6187.
12. Navarro-Sabate A., Manzano A., Riera L., Rosa J.L., Ventura F., Bartrons R. The human ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3) promoter characterization and genomic structure . Gene. 264:2001;131-138.
13. Okar D.A., Manzano A., Navarro-Sabate A., Riera L., Bartrons R., Lange A.J. PFK-2/FBPase-2 maker and breaker of the essential biofactor fructose-2,6-bisphosphate . Trends Biochem. Sci. 26:2001;30-35.
14. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24:1999;68-72.
15. Boada J., Roig T., Perez X., Gamez A., Bartrons R., Cascante M., Bermudez J. Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett. 480:2000;261-264.
16. Perez J.X., Roig T., Manzano A., Dalmau M., Boada J., Ventura F., Rosa J.L., Bermudez J., Bartrons R. Overexpression of fructose 2,6-bisphosphatase decreases glycolysis and delays cell cycle progression. Am. J. Physiol. Cell Physiol. 279:2000;C1359-C1365.
17. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
18. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies integrating mammalian biology . Cell. 104:2001;487-501.
19. Obrador E., Navarro J., Mompo J., Asensi M., Pellicer J.A., Estrela J.M. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Biochem. J. 325:1997;183-189.
20. Haddad J.J.E., Olver R.E., Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem. 275:2000;21130-21139.
21. Janssen-Heininger Y.M., Macara I., Mossman B.T. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants . Am. J. Respir. Cell Mol. Biol. 20:1999;942-952.
22. Carretero J., Obrador E., Pellicer J.A., Pascual A., Estrela J.M. Mitochondrial glutathione depletion by glutamine in growing tumor cells. Free Radic. Biol. Med. 29:2000;913-923.
23. Obrador E., Carretero J., Esteve J.M., Pellicer J.A., Pascual A., Petschen I., Estrela J.M. Glutamine potentiates TNF-alpha-induced tumor cytotoxicity. Free Radic. Biol. Med. 31:2001;642-650.
24. Haycock J.W., Rowe S.J., Cartledge S., Wyatt A., Ghanem G., Morandini R., Rennie I.G., MacNeil S. Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J. Biol. Chem. 275:2000;15629-15636.
25. Arrigo A.P. Gene expression and the thiol redox state. Free Radic. Biol. Med. 27:1999;936-944.
26. Rahman I. Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells. Biochem. Pharmacol. 60:2000;1041-1049.
27. Lallemand F., Mazars A., Prunier C., Bertrand F., Kornprost M., Gallea S., Roman-Roman S., Cherqui G., Atfi A. Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene. 20:2001;879-884.
28. Kelley J., Baldor L., Absher M. Complex cytokine modulation of a continuous line of mink lung epithelial cells (Mv1Lu). Exp. Lung Res. 18:1992;877-887.
29. Chalaux E., Lopez-Rovira T., Rosa J.L., Pons G., Boxer L.M., Bartrons R., Ventura F. A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett. 457:1999;478-482.
30. Aebi H.E. Catalase in vitro. Bergmeyer H.U., Methods of enzymatic abalysis. vol. 3:1983;273-286 Academic Press, New York.
31. Seelig G.F., Meister A. Gamma-glutamylcysteine synthetase. Interactions of an essential sulfhydryl group. J. Biol. Chem. 259:1984;3534-3538.
32. Senft A.P., Dalton T.P., Shertzer H.G. Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde. Anal. Biochem. 280:2000;80-86.
33. Pierce R.H., Campbell J.S., Stephenson A.B., Franklin C.C., Chaisson M., Poot M., Kavanagh T.J., Rabinovitch P.S., Fausto N. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am. J. Pathol. 157:2000;221-236.
34. Cantin A.M., Paquette B., Richter M., Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am. J. Respir. Crit. Care Med. 162:2000;1539-1546.
35. Schmidt K.N., Traenckner E.B., Meier B., Baeuerle P.A. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B. J. Biol. Chem. 270:1995;27136-27142.
36. Traenckner E.B., Pahl H.L., Henkel T., Schmidt K.N., Wilk S., Baeuerle P.A. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14:1995;2876-2883.
37. Davis D.A., Newcomb F.M., Starke D.W., Ott D.E., Mieyal J.J., Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 272:1997;25935-25940.
38. Piwocka K., Jaruga E., Skierski J., Gradzka I., Sikora E. Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells. Free Radic. Biol. Med. 31:2001;670-678.
39. Rahman I., Antonicelli F., MacNee W. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J. Biol. Chem. 274:1999;5088-5096.
40. Urata Y., Yamamoto H., Goto S., Tsushima H., Akazawa S., Yamashita S., Nagataki S., Kondo T. Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1beta and tumor necrosis factor-alpha in mouse endothelial cells. J. Biol. Chem. 271:1996;15146-15152.
41. Gao L., Kim K.J., Yankaskas J.R., Forman H.J. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am. J. Physiol. 277:1999;L113-L118.
42. 2-mediated oxidative stress activates NF-kappaB in lens epithelial cells. Free Radic. Biol. Med. 31:2001;651-658.
43. Okamoto T., Sakurada S., Yang J.P., Merin J.P. Regulation of NF-kappa B and disease control identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation . Curr. Top. Cell. Regul. 35:1997;149-161.
44. Daily D., Vlamis-Gardikas A., Offen D., Mittelman L., Melamed E., Holmgren A., Barzilai A. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1. J. Biol. Chem. 276:2001;1335-1344.
45. Manna S.K., Kuo M.T., Aggarwal B.B. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene. 18:1999;4371-4382.
46. Hall A.G. Review the role of glutathione in the regulation of apoptosis . Eur. J. Clin. Invest. 29:1999;238-245.
47. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107:2001;241-246.
48. Lewandowicz G.M., Britt P., Elgie A.W., Williamson C.J., Coley H.M., Hall A.G., Sargent J.M. Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer. Gynecol. Oncol. 85:2002;298-304.
49. Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladino M.A. Jr, Shepard H.M. Recombinant human tumor necrosis factor-alpha effects on proliferation of normal and transformed cells in vitro . Science. 230:1985;943-945.
50. Sugarman B.J., Lewis G.D., Eessalu T.E., Aggarwal B.B., Shepard H.M. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res. 47:1987;780-786.
51. 2-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis. FASEB J. 14:2000;2266-2276.
52. Ray G., Batra S., Shukla N.K., Deo S., Raina V., Ashok S., Husain S.A. Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res. Treat. 59:2000;163-170.
53. Yabuki M., Kariya S., Ishisaka R., Yasuda T., Yoshioka T., Horton A.A., Utsumi K. Resistance to nitric oxide-mediated apoptosis in HL-60 variant cells is associated with increased activities of Cu,Zn-superoxide dismutase and catalase. Free Radic. Biol. Med. 26:1999;325-332.
54. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:2002;47-95.
55. Blackburn R.V., Spitz D.R., Liu X., Galoforo S.S., Sim J.E., Ridnour L.A., Chen J.C., Davis B.H., Corry P.M., Lee Y.J. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic. Biol. Med. 26:1999;419-430.
56. Mazurek S., Boschek C.B., Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J. Bioenerg. Biomembr. 29:1997;315-330.
57. Brand K.A., Hermfisse U. Aerobic glycolysis by proliferating cells a protective strategy against reactive oxygen species . FASEB J. 11:1997;388-395.
58. Durante P., Gueuning M.A., Darville M.I., Hue L., Rousseau G.G. Apoptosis induced by growth factor withdrawal in fibroblasts overproducing fructose 2,6-bisphosphate. FEBS Lett. 448:1999;239-243.
59. Perez J.X., Manzano A., Tauler A., Bartrons R. Effect of starvation on gene expression of regulatory enzymes of glycolysis/gluconeogenesis in genetically obese (fa/fa) Zucker rats. Int. J. Obes. Relat. Metab. Disord. 22:1998;667-672.
60. Soltys K., Dikdan G., Koneru B. Oxidative stress in fatty livers of obese Zucker rats rapid amelioration and improved tolerance to warm ischemia with tocopherol . Hepatology. 34:2001;13-18.
61. 2 and NO stresses. Biochem. J. 364:2002;349-359.
62. Haddad J.J. Glutathione depletion is associated with augmenting a proinflammatory signal evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium . Cytokines Cell. Mol. Ther. 6:2000;177-187.
63. Abate C., Patel L., Rauscher F.J. III, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science. 249:1990;1157-1161.
64. Lopez-Rovira T., Chalaux E., Rosa J.L., Bartrons R., Ventura F. Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J. Biol. Chem. 275:2000;28937-28946.
65. Baichwal V.R., Baeuerle P.A. Activate NF-kappa B or die? Curr. Biol. 7:1997;R94-R96.
66. Mayo M.W., Baldwin A.S. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta. 1470:2000;M55-M62.
67. Stark L.A., Din F.V., Zwacka R.M., Dunlop M.G. Aspirin-induced activation of the NF-kappaB signaling pathway a novel mechanism for aspirin-mediated apoptosis in colon cancer cells . FASEB J. 15:2001;1273-1275.
68. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., Thanos D., Rosenfeld M.G., Glass C.K., Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 19:1999;6367-6378.
69. Barkett M., Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6910-6924.
70. Ros J., Schuetz J., Geuken M., Streetz K., Moshage H., Kuipers F., Manns M., Jansen P., Trautwein C., Muller M. Induction of Mdr1b expression by tumor necrosis factor-[alpha] in rat liver cells is independent of p53 but requires NF-[kappa]B signaling. Hepatology. 33:2001;1425-1431.